A potential coronavirus vaccine developed by Oxford University has produced a strong immune response in a large, early-stage human trial, according to newly released data published Monday in the medical journal The Lancet.
Trials involving around 1,077 people showed the injection led to them making antibodies and white blood cells that can fight coronavirus.
https://www.thelancet.com/lancet/article/s0140-6736(20)31604-4
